PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.07%
Revenue growth similar to QCOM's 6.42%. Walter Schloss would see if both companies share industry tailwinds.
7.06%
Gross profit growth above 1.5x QCOM's 2.85%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
12.90%
EBIT growth below 50% of QCOM's 109.75%. Michael Burry would suspect deeper competitive or cost structure issues.
13.14%
Operating income growth under 50% of QCOM's 109.75%. Michael Burry would be concerned about deeper cost or sales issues.
11.74%
Net income growth under 50% of QCOM's 235.81%. Michael Burry would suspect the firm is falling well behind a key competitor.
12.59%
EPS growth under 50% of QCOM's 268.18%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
12.86%
Diluted EPS growth under 50% of QCOM's 268.18%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.82%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.80%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.16%
Dividend growth under 50% of QCOM's 8.10%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
15.33%
OCF growth under 50% of QCOM's 297.87%. Michael Burry might suspect questionable revenue recognition or rising costs.
10.08%
FCF growth under 50% of QCOM's 455.59%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
69.30%
10Y revenue/share CAGR at 50-75% of QCOM's 123.01%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
48.57%
5Y revenue/share CAGR above 1.5x QCOM's 4.79%. David Dodd would look for consistent product or market expansions fueling outperformance.
30.76%
3Y revenue/share CAGR above 1.5x QCOM's 4.45%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
169.40%
10Y OCF/share CAGR at 75-90% of QCOM's 205.21%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
106.95%
5Y OCF/share CAGR above 1.5x QCOM's 15.50%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
57.28%
3Y OCF/share CAGR above 1.5x QCOM's 5.56%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
275.27%
Net income/share CAGR above 1.5x QCOM's 79.29% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
182.32%
Positive 5Y CAGR while QCOM is negative. John Neff might view this as a strong mid-term relative advantage.
107.02%
3Y net income/share CAGR above 1.5x QCOM's 12.01%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
40.20%
10Y equity/share CAGR at 75-90% of QCOM's 50.83%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
7.63%
Positive 5Y equity/share CAGR while QCOM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
10.99%
Positive short-term equity growth while QCOM is negative. John Neff sees a strong advantage in near-term net worth buildup.
518.41%
10Y dividend/share CAGR above 1.5x QCOM's 283.99%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
121.07%
5Y dividend/share CAGR above 1.5x QCOM's 76.24%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
82.03%
3Y dividend/share CAGR above 1.5x QCOM's 30.93%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
2.19%
Our AR growth while QCOM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
1.24%
We show growth while QCOM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.25%
Positive asset growth while QCOM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.29%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.02%
We have some new debt while QCOM reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
1.56%
R&D growth drastically higher vs. QCOM's 1.00%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-10.20%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.